Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis

被引：19
作者：
Younus, J. [1 ]
Vandenberg, T. [1 ]
Jawaid, M. [2 ]
Jawaid, M. A. [3 ]
机构：
[1] London Reg Canc Program, Dept Med Oncol, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, Schulich Sch Med, London, ON, Canada
[3] Univ Western Ontario, Dept Social Sci, London, ON, Canada
来源：
CURRENT ONCOLOGY | 2012年 / 19卷 / 06期
关键词：
Febrile neutropenia; breast cancer; adjuvant chemotherapy; RANDOMIZED-TRIALS; METAANALYSIS; DOXORUBICIN; OUTCOMES; OLDER;
D O I：
10.3747/co.19.1174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：332 / 334
页数：3
相关论文
共 47 条
[31]   FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) [J].
Polyzos, Aristides ;
Malamos, Nikolaos ;
Boukovinas, Ioannis ;
Adamou, Adamos ;
Ziras, Nikolaos ;
Kalbakis, Kostas ;
Kakolyris, Stylianos ;
Syrigos, Kostas ;
Papakotoulas, Pavlos ;
Kouroussis, Charalambos ;
Karvounis, Nikolaos ;
Vamvakas, Lambros ;
Christophyllakis, Charalambos ;
Athanasiadis, Athanasios ;
Varthalitis, Ioannis ;
Georgoulias, Vassilis ;
Mavroudis, Dimitris .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) :95-104
[32]   FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) [J].
Aristides Polyzos ;
Nikolaos Malamos ;
Ioannis Boukovinas ;
Adamos Adamou ;
Nikolaos Ziras ;
Kostas Kalbakis ;
Stylianos Kakolyris ;
Kostas Syrigos ;
Pavlos Papakotoulas ;
Charalambos Kouroussis ;
Nikolaos Karvounis ;
Lambros Vamvakas ;
Charalambos Christophyllakis ;
Athanasios Athanasiadis ;
Ioannis Varthalitis ;
Vassilis Georgoulias ;
Dimitris Mavroudis .
Breast Cancer Research and Treatment, 2010, 119 :95-104
[33]   Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors [J].
Pfeil, Alena M. ;
Vulsteke, Christof ;
Paridaens, Robert ;
Dieudonne, Anne-Sophie ;
Pettengell, Ruth ;
Hatse, Sigrid ;
Neven, Patrick ;
Lambrechts, Diether ;
Szucs, Thomas D. ;
Schwenkglenks, Matthias ;
Wildiers, Hans .
BMC CANCER, 2014, 14
[34]   Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors [J].
Alena M Pfeil ;
Christof Vulsteke ;
Robert Paridaens ;
Anne-Sophie Dieudonné ;
Ruth Pettengell ;
Sigrid Hatse ;
Patrick Neven ;
Diether Lambrechts ;
Thomas D Szucs ;
Matthias Schwenkglenks ;
Hans Wildiers .
BMC Cancer, 14
[35]   Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials [J].
Rafael Caparica ;
Marco Bruzzone ;
Francesca Poggio ;
Marcello Ceppi ;
Evandro de Azambuja ;
Matteo Lambertini .
Breast Cancer Research and Treatment, 2019, 174 :27-37
[36]   Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China:A pooled retrospective analysis of four observational studies [J].
Binghe Xu ;
Zhimin Shao ;
Shui Wang ;
Zefei Jiang ;
Xichun Hu ;
Xiaohua Zhang ;
Xiru Li ;
Jinping Liu ;
Mengquan Li ;
Shu Wang .
Chinese Journal of Cancer Research, 2018, 30 (03) :327-339
[37]   Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group [J].
Mavroudis, Dimitrios ;
Saloustros, Emmanouil ;
Boukovinas, Ioannis ;
Papakotoulas, Pavlos ;
Kakolyris, Stylianos ;
Ziras, Nikolaos ;
Christophylakis, Charalampos ;
Kentepozidis, Nikolaos ;
Fountzilas, Georgios ;
Rigas, Georgios ;
Varthalitis, Ioannis ;
Kalbakis, Konstantinos ;
Agelaki, Sofia ;
Hatzidaki, Dora ;
Georgoulias, Vasilios .
BRITISH JOURNAL OF CANCER, 2017, 117 (02) :164-170
[38]   Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG) [J].
Mavroudis, D. ;
Matikas, A. ;
Malamos, N. ;
Papakotoulas, P. ;
Kakolyris, S. ;
Boukovinas, I. ;
Athanasiadis, A. ;
Kentepozidis, N. ;
Ziras, N. ;
Katsaounis, P. ;
Saloustros, E. ;
Georgoulias, V. .
ANNALS OF ONCOLOGY, 2016, 27 (10) :1873-1878
[39]   Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials [J].
Jacquin, Jean-Philippe ;
Jones, Stephen ;
Magne, Nicolas ;
Chapelle, Celine ;
Ellis, Paul ;
Janni, Wolfgang ;
Mavroudis, Dimitrios ;
Martin, Miguel ;
Laporte, Silvy .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) :903-913
[40]   Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials [J].
Jean-Philippe Jacquin ;
Stephen Jones ;
Nicolas Magné ;
Céline Chapelle ;
Paul Ellis ;
Wolfgang Janni ;
Dimitrios Mavroudis ;
Miguel Martín ;
Silvy Laporte .
Breast Cancer Research and Treatment, 2012, 134 :903-913
12345